A system and method for in vitro analysis of therapeutic agents comprising a
reservoir
adapted to hold a therapeutic agent, a first flow cell having a first cell chamber
adapted to receive at least a first sample of the therapeutic agent, a second flow
cell having a second cell chamber adapted to receive at least a second sample of
the therapeutic agent, the first flow cell having a first path length (be)
and the second flow cell having a second path length (be"), the first
path length being substantially equal to a sensitivity factor (f)be",
a membrane chamber having a biological cell membrane therein adapted to receive
at least a third sample of the therapeutic agent, the membrane chamber being further
adapted to detect the membrane potential of the biological cell membrane; and spectroscopic
detection means for detecting the spectral characteristics of the first and second
therapeutic agent samples.